NASDAQ:AFMD
Affimed N.V. Stock News
$5.35
-0.140 (-2.55%)
At Close: Apr 30, 2024
Affimed Announces First Patient Successfully Dosed in First-in-Human Phase –/—A Study of ...
12:00am, Thursday, 16'th Apr 2020Solebury Trout Announces Additional Virtual Conference Presentations from Life Science Companies on April 7, 2020
07:15pm, Monday, 06'th Apr 2020
NEW YORK, NY / ACCESSWIRE / April 6, 2020 / Solebury Trout, a boutique investor relations and corporate communications firm, announced today that it will be hosting a fourth day of presentations as pa
Stocks To Watch: OPEC Goes Virtual
01:04pm, Saturday, 04'th Apr 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Here's a roundup of top developments in the biotech space over the last 24 hours.On a day when the three major averages shed over 4% in reaction to bleak forecasts concerning the COVID-19 pandemic's
Affimed Provides COVID-19-Related Business Update and Announces Full Year 2019 Financial Results Conference Call on April 28, 2020
10:30am, Thursday, 02'nd Apr 2020
Heidelberg, Germany, April 2, 2020 – Affimed N.V. (AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today provided an update o
Citigroup Inc. Has $57,000 Position in Affimed NV (NASDAQ:AFMD)
09:52am, Thursday, 02'nd Apr 2020
Citigroup Inc. grew its position in Affimed NV (NASDAQ:AFMD) by 606.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor o
Affimed Provides COVID-–9-Related Business Update and Announces Full Year —…–9 ...
12:00am, Thursday, 02'nd Apr 2020Affimed Reports FDA Orphan Drug Designation For AFM13 For Treatment Of T-Cell Lymphoma
08:01pm, Wednesday, 01'st Apr 2020Affimed Announces FDA Granted Orphan Drug Designation for Lead Innate Cell Engager AFM13 for the Treatment of T-cell Lymphoma
08:01pm, Wednesday, 01'st Apr 2020
Heidelberg, Germany, April 1, 2020 – Affimed N.V. (AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that the U
Affimed Announces Participation at Upcoming Virtual Investor Conferences
11:30am, Thursday, 26'th Mar 2020
Heidelberg, Germany, March 26, 2020 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight.
Affimed Announces Participation at Upcoming Virtual Investor Conferences
12:00am, Thursday, 26'th Mar 2020Solebury Trout Announces Virtual Conference Series with Presentations from Life Science Companies
08:00pm, Tuesday, 24'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 24, 2020 / Solebury Trout, a boutique investor relations and corporate communications firm, announced today that it will be hosting a Virtual Conference Series on Mar
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 16.) * BioNTech SE - ADR (NASDAQ: BNTX) (announced eff
Affimed Announces Appointment of Arndt Schottelius, M.D. Ph.D. as Chief Scientific Officer
11:30am, Tuesday, 17'th Mar 2020
Heidelberg, Germany, March 17, 2020 – Affimed N.V. (AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced the appoi
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) * Masimo Corporation (NASDAQ: MASI)Down In The Dum
